(Q35570913)

8 August 2017

title

Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections (English)

1 reference

8 August 2017

author

Ellie J. C. Goldstein

series ordinal

1

object named as

Goldstein EJ

1 reference

8 August 2017

Alpert ML

2

1 reference

8 August 2017

Ginsberg BP

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 March 1985

1 reference

Antimicrobial Agents and Chemotherapy

8 August 2017

published in

1 reference

8 August 2017

volume

27

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

422-423

1 reference

Multicenter evaluation of the proposed quality control limits and interpretive zone standards for in vitro susceptibility testing with norfloxacin

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176290

Norfioxacin (MK–0366) treatment of urinary tract infections in hospitalized patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176290

Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176290

Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176290

In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176290

In vitro antibacterial activity of norfloxacin (MK-0366).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176290

Mortality associated with nosocomial urinary-tract infection

12 July 2018

1 reference

12 December 2020

Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of norfloxacin

1 reference

12 December 2020

Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage

1 reference

12 December 2020

Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections

1 reference

12 December 2020

Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections

1 reference

12 December 2020

Disk diffusion susceptibility tests with norfloxacin: confirmation of proposed interpretive criteria

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.27.3.422

1 reference

8 August 2017

1 reference

8 August 2017

1 reference